Adi announces u.s. fda 510(k) clearance and the commercial launch of sensinel by analog devices™ cardiopulmonary management (cpm) system

Enabling closer remote patient monitoring and reduced healthcare costs wilmington, mass. , march 5, 2024 /prnewswire/ -- analog devices, inc. (nasdaq: adi) today announced u.s. food and drug administration (fda) 510(k) clearance and the commercial launch of the sensinel™ cardiopulmonary management (cpm) system.

ADI Ratings Summary

ADI Quant Ranking